权威例句
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
Addition of low‐dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients
The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction
An International Study of the Effects of Rosiglitazone plus Sulphonylurea in Patients with Type 2 Diabetes
The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways
The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients wit...
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 d...